CD8A and neoplasm: Moreover, it may downregulate PD-L1 expression on vascular endothelial cells through the inactivation of AKT pathway, thereby improving the ratio of CD8 T cells/FoxP3 T cells inside the tumor and remolding the immune microenvironment (43).